Risk of serious conditions reduced regardless of amount of weight lost, say researchers who compare breakthrough to discovery ...
Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could ...
Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
The weight loss jab has become a blockbuster pharmaceutical hit, with people, including the diabetics it was originally ...
Find your bookmarks in your Independent Premium section, under my profile Weight loss jabs like Ozempic can cut the risk of ... semaglutide reduced the risk of a heart attack or stroke in obese ...
Weight loss injections ... placebo group), the reduction in heart attack, stroke, or heart failure risk seemed independent of weight loss. This suggests the drug might have other mechanisms ...
Ozempic is a drug ... risk of a heart attack, stroke or cardiovascular disease, that's regardless of how much weight they lost. "That goes to show that this drug does more than just cause weight ...
A weight loss injection could reduce the risk of ... had a 20 per cent lower risk of heart attack, stroke or death due to cardiovascular disease. The study, presented at the European Congress ...
As a major study shows it cuts heart attack risks experts say semaglutide could 'transform many chronic diseases of ageing' ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
Study adds to evidence that semaglutide, also known by the brand names Ozempic or Wegovy, can be used for a range of chronic conditions ...